Daveen Chopra - 15 Dec 2023 Form 4 Insider Report for Edwards Lifesciences Corp (EW)

Role: CVP, TMTT
Signature: Linda J. Park, Attorney-in-Fact
Issuer symbol: EW
Transactions as of: 15 Dec 2023
Net transactions value: -$132,927
Form type: 4
Filing time: 15 Dec 2023, 17:22:12 UTC
Previous filing: 06 Dec 2023
Next filing: 21 Feb 2024
SEC: View on sec.gov

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	EW	Common Stock	Options Exercise	$414,797	+7,000	+29%	$59.26	30,950	15 Dec 2023	Direct
transaction	EW	Common Stock	Sale	$547,724	-7,000	-23%	$78.25	23,950	15 Dec 2023	Direct	F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	EW	Employee Stock Option (Right to Acquire)	Options Exercise	$0	-7,000	-50%	$0.000000	7,000	15 Dec 2023	Common Stock	7,000	$59.26	Direct

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	This transaction was executed in multiple trades at prices ranging from $78.24 to $78.25. The price reported above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide, upon request by the SEC staff, the Issuer, or a security holder of the Issuer, full information regarding the number of shares and prices at which the transaction was effected.

Remarks:

This Form 4 reflects changes in beneficial ownership only; it does not identify other securities of the Issuer beneficially owned by the Reporting Person.